Rankings
▼
Calendar
MLYS Q2 2022 Earnings — Mineralys Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
MLYS
Mineralys Therapeutics, Inc.
$2B
Q2 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$6M
Net Income
-$6M
EPS (Diluted)
$-1.26
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$26,000
← FY 2022
All Quarters
Q3 2022 →
